2018
- Targeting Chemokine Receptor CXCR4 and Translocator Protein for Characterization of High-Risk Plaque in Carotid Stenosis Ex Vivo
- Imaging of chemokine receptor CXCR4 expression in culprit and nonculprit coronary atherosclerotic plaque using motion-corrected [68Ga]pentixafor PET/CT
- Anti-Inflammatory Effects on Atherosclerotic Lesions Induced by CXCR4-Directed Endoradiotherapy
- [68Ga]Ga-Pentixafor PET/MRI for CXCR4 Imaging of Chronic Lymphocytic Leukemia: Preliminary Results
- Feasibility of CXCR4-directed radioligand therapy in advanced diffuse large B cell lymphoma
- Isolated metastasis of an EGFR-L858R-mutated NSCLC of the meninges: the potential impact of CXCL12/CXCR4 axis in EGFRmut NSCLC in diagnosis, follow-up and treatment
- [68Ga]Pentixafor-PET/MRI for the detection of Chemokine receptor 4 expression in atherosclerotic plaques
- Seeing the unseen: post-infarction inflammation in an isolated right ventricular myocardial infarction visualized by combined cardiac magnetic resonance imaging and chemokine receptor CXCR4-targeted molecular imaging
- CXCR4 Is a Potential Target for Diagnostic PET/CT Imaging in Barrett's Dysplasia and Esophageal Adenocarcinoma
- Imaging of C-X-C Motif Chemokine Receptor CXCR4 Expression After Myocardial Infarction With [68Ga]Pentixafor-PET/CT in Correlation With Cardiac MRI
- Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma
- Clinical Molecular Imaging of Chemokine Receptor CXCR4 Expression in Atherosclerotic Plaque Using 68Ga-Pentixafor PET: Correlation with Cardiovascular Risk Factors and Calcified Plaque Burden
- 68Ga-Pentixafor PET/CT Imaging of Chemokine Receptor CXCR4 in Chronic Infection of the Bone: First Insights
- Potential influence of concomitant chemotherapy on CXCR4 expression in receptor directed endoradiotherapy
- Dual Targeting of Acute Leukemia and Supporting Niche by CXCR4-Directed Theranostics
2017
- [177Lu]pentixather: comprehensive preclinical evaluation of a first CXCR4-directed endoradiotherapeutic agent
- [68Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma – Comparison to [18F]FDG and laboratory values
- [64Cu]NOTA-pentixather enables high resolution PET imaging of CXCR4 expression in a preclinical lymphoma model
2016
- Investigating the Chemokine Receptor 4 as Potential Theranostic Target in Adrenocortical Cancer Patients
- Imaging the cytokine receptor CXCR4 in atherosclerotic plaques with the radiotracer 68Ga-pentixafor for positron emission tomography
- Preclinical evaluation of [(68)Ga]NOTA-pentixafor for PET imaging of CXCR4 expression in vivo - a comparison to [(68)Ga]pentixafor
- [68Ga]Pentixafor-Positron Emission Tomography/Computed Tomography Detects Chemokine Receptor CXCR4 Expression After Ischemic Stroke
- First 18F-labeled Pentixafor-based Imaging Agent for PET Imaging of CXCR4-expression in Vivo
- Targeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemia
- The influence of different metal-chelate conjugates of pentixafor on the CXCR4 affinity
- (68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma
- [68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer-initial experience
- First Experience with Chemokine Receptor CXCR4-Targeted PET Imaging of Patients with Solid Cancers
2015
- [(68)Ga]Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression After Myocardial Infarction
- Upregulated myocardial CXCR4-expression after myocardial infarction assessed by simultaneous GA-68 pentixafor PET/MRI
- First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease
- Molecular Imaging of the Chemokine Receptor CXCR4 After Acute Myocardial Infarction
- In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma
- Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging
- Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68Ga-pentixafor
Ältere
- PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent
- A conformationally frozen peptoid boosts CXCR4 affinity and anti-HIV activity
- Design, synthesis, and functionalization of dimeric peptides targeting chemokine receptor CXCR4
- PET imaging of CXCR4 receptors in cancer by a new optimized ligand
- Introduction of functional groups into peptides via N-alkylation